Provided by Tiger Trade Technology Pte. Ltd.

Jasper Therapeutics

0.7160
+0.02483.59%
Post-market: 0.73080.0148+2.06%18:14 EDT
Volume:780.85K
Turnover:546.45K
Market Cap:23.82M
PE:-0.45
High:0.7357
Open:0.6800
Low:0.6750
Close:0.6912
52wk High:3.05
52wk Low:0.3151
Shares:33.27M
Float Shares:30.00M
Volume Ratio:0.65
T/O Rate:2.60%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.5797
EPS(LYR):-3.9545
ROE:-255.05%
ROA:-113.41%
PB:16.86
PE(LYR):-0.18

Loading ...

Company Profile

Company Name:
Jasper Therapeutics
Exchange:
NASDAQ
Establishment Date:
2018
Employees:
22
Office Location:
2200 Bridge Pkwy,Suite 102,Redwood City,California,United States
Zip Code:
94065
Fax:
- -
Introduction:
Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on the development and commercialization of therapeutic agents for diseases, such as chronic spontaneous urticaria, lower to intermediate risk myelodysplastic syndrome, and novel conditioning regimens for stem cell transplantation and ex-vivo gene therapy, a technique in which genetic manipulation of cells is performed outside of the body prior to transplantation. The company's lead product candidate is briquilimab, which is in clinical development as a novel therapeutic antibody that clears hematopoietic stem cells from bone marrow in patients prior to undergoing allogeneic stem cell therapy or stem cell gene therapy. It is also developing engineered hematopoietic stem cells product candidates to overcome key limitations of allogeneic and autologous gene-edited stem cell grafts. The company is headquartered in Redwood City, California.

Directors

Name
Position
Jeet Mahal
Chief Executive Officer,Director and President
Kurt von Emster
Independent Director
Scott Brun
Independent Director
Svetlana Lucas
Independent Director
Tom Wiggans
Executive Chairperson of the Board
Vishal Kapoor
Independent Director
Judith Shizuru
Director

Shareholders

Name
Position
Jeet Mahal
Chief Executive Officer,Director and President
Herb Cross
Chief Financial Officer and Corporate Secretary
Tom Wiggans
Executive Chairperson of the Board